The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product launches will facilitate significant procedure volume expansion. However, cost constraints in the publicly funded health care system continue to hinder penetration of endovascular treatment; as a result, the Canadian PV device market will grow modestly through 2025, despite rising PVD diagnosis rates.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Canada across a 10-year period.


Endovascular PV adoption in Canada is significantly behind other developed health care markets, such as the US and Europe.

What factors contribute to this delay in adoption?

Will the uptake of endovascular techniques improve in Canada in the future?

What strategies can manufacturers implement to boost PV device use in Canada?

Manufacturers in Canada compete for hospital tender contracts.

How has this practice affected the Canadian PV competitive landscape?

To what degree will price competition to win contracts affect the market overall?

Peripheral DCBs for the fem-pop indication were launched in Canada in 2016.

To what extent will these devices be adopted amid cost-containment efforts?

How will adoption of these devices affect ASPs and market growth?

Table of contents

  • Canada
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Key Report Updates
      • Average Currency Exchange Rates
      • Procedures Covered
      • Products Covered
    • Version History
    • Peripheral Vascular Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication (Procedures Only)
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies
        • Market Appeal
        • Clinical Data
        • First-Mover Advantage
        • Competition from Alternatives
        • Physician Training and Marketing
      • Market Developments
    • Peripheral Vascular Stent Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Competition from Alternatives
        • Physician Training and Marketing
    • PTA Balloon Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication
        • By Product Type
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies
        • Market Appeal
        • Clinical Data
    • Chronic Total Occlusion Crossing Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Embolic Protection Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Surgical Graft Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Peripheral Vascular Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Fernando Amador, PhD

Fernando Amador is a principal analyst within the Cardiovascular Medtech Insights team at Decision Resources Group; he is DRG's authority on peripheral vascular and cardiac assist devices. Fernando holds a in Medical Biophysics from the Universtiy of Toronto, where he was a Banting and Best Scholar.


Related Reports

Peripheral Vascular Devices | Medtech 360 | Market Insights | United States

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for sign...

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | Europe

The European market for PV devices is evolving, and new product launches backed by clinical evidence will allow for significant expansion throu...

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | Europe (Supplemental)

The European market for PV devices continues to expand, driven primarily by procedure volume growth in the lower-limb indications and...

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | Europe Part 2

The European market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will all...

View Details